Old Web
English
Sign In
Acemap
>
authorDetail
>
M Jenkins
M Jenkins
AstraZeneca
Internal medicine
Medicine
Biomarker (medicine)
Confounding
Physiology
4
Papers
5
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and Efficacy of Budesonide-Glycopyrrolate-Formoterol Fumarate for COPD in Black or African-American Patients: A Post-Hoc Subgroup Analysis of the ETHOS Study
2021
M.K. Han
M Jenkins
D. Carstens
M. Patel
N. Feigler
Show All
Source
Cite
Save
Citations (1)
The Cost of a Severe Chronic Obstructive Pulmonary Disease (COPD) Exacerbation, Estimated from Recent Triple Therapy Studies in Patients with COPD: KRONOS and ETHOS
2020
E de Nigris
Ulf Holmgren
M. Aurivillius
M Jenkins
Show All
Source
Cite
Save
Citations (0)
. Assessment of diurnal changes and confounding factors that affect circulating cell death biomarker levels: A short communication.
2013
Journal of Pharmaceutical and Biomedical Analysis
Alastair Greystoke
G Harris
M Jenkins
D Goonetilleke
David Moore
Matthew Lancashire
Malcolm R Ranson
Adina Hughes
Glen Clack
Caroline Dive
Show All
Source
Cite
Save
Citations (4)
Assessment of diurnal changes and confounding factors that affect circulating cell death biomarker levels; a short communication
2013
Journal of Pharmaceutical and Biomedical Analysis
Alastair Greystoke
G Harris
M Jenkins
D Goonetilleke
David Moore
Matthew Lancashire
Malcolm R Ranson
Adina Hughes
Glen Clack
Caroline Dive
Show All
Source
Cite
Save
Citations (0)
1